ID   MADB106
AC   CVCL_BT04
SY   MADB-106; MADB 106
DR   CCRID; 4201RAT-CCTCC00130
DR   CCTCC; GDC0130
DR   CLS; 305205
DR   KCB; KCB 2013045YJ
DR   NCI-DTP; MADB 106
DR   Wikidata; Q54903970
RX   DOI=10.1007/BF00199175;
RX   PubMed=10220071;
CC   Characteristics: Obtained from a pulmonary metastasis produced by the intra-venous injection of MADB100 tumor cells (DOI=10.1007/BF00199175).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F0WZ ! MADB100
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 13
//
RX   DOI=10.1007/BF00199175;
RA   Sone, Saburo
RA   Fidler, Isaiah Joshua
RT   "In situ activation of tumoricidal properties in rat alveolar
RT   macrophages and rejection of experimental lung metastases by
RT   intravenous injections of Nocardia rubra cell wall skeleton.";
RL   Cancer Immunol. Immunother. 12:203-209(1982).
//
RX   PubMed=10220071; DOI=10.1016/S0145-305X(98)00040-8;
RA   Page, Gayle Giboney
RA   Ben-Eliyahu, Shamgar
RT   "A role for NK cells in greater susceptibility of young rats to
RT   metastatic formation.";
RL   Dev. Comp. Immunol. 23:87-96(1999).
//